230 related articles for article (PubMed ID: 24390220)
1. Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.
Sangle NA; Schmidt RL; Patel JL; Medeiros LJ; Agarwal AM; Perkins SL; Salama ME
Mod Pathol; 2014 Aug; 27(8):1137-43. PubMed ID: 24390220
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological analysis of 46 cases with CD4
Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
[TBL] [Abstract][Full Text] [Related]
3. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm.
Sukswai N; Aung PP; Yin CC; Li S; Wang W; Wang SA; Ortega V; Lyapichev K; Nagarajan P; Alfattal R; Angelova E; Tang Z; Loghavi S; Kanagal-Shamanna R; Miranda RN; Pemmaraju N; Bhalla K; Konopleva M; Medeiros LJ; Khoury JD
Am J Surg Pathol; 2019 Oct; 43(10):1429-1437. PubMed ID: 31261288
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.
Cronin DM; George TI; Reichard KK; Sundram UN
Am J Clin Pathol; 2012 Mar; 137(3):367-76. PubMed ID: 22338048
[TBL] [Abstract][Full Text] [Related]
5. IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression.
Tang H; Panse G; Braddock D; Perincheri S; Xu ML; McNiff JM
J Cutan Pathol; 2023 Jul; 50(7):595-600. PubMed ID: 37082914
[TBL] [Abstract][Full Text] [Related]
6. Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells.
Wu SJ; Sadigh S; Lane AA; Pinkus GS
Am J Clin Pathol; 2023 May; 159(5):455-463. PubMed ID: 36880313
[TBL] [Abstract][Full Text] [Related]
7. Comparison and Development of Immunohistochemical Diagnostic Criteria for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Sakamoto K; Baba S; Okumura Y; Momose S; Ono S; Tonooka A; Ichinohasama R; Takakuwa E; Nakasone H; Ohshima K; Takeuchi K
Mod Pathol; 2023 Oct; 36(10):100253. PubMed ID: 37380058
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
[TBL] [Abstract][Full Text] [Related]
9. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
Zhang X; Wu Y; Li C; Shen K; Li R
Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129
[TBL] [Abstract][Full Text] [Related]
11. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients.
Julia F; Dalle S; Duru G; Balme B; Vergier B; Ortonne N; Vignon-Pennamen MD; Costes-Martineau V; Lamant L; Dalac S; Delattre C; Déchelotte P; Courville P; Carlotti A; De Muret A; Fraitag S; Levy A; Mitchell A; Petrella T
Am J Surg Pathol; 2014 May; 38(5):673-80. PubMed ID: 24441662
[TBL] [Abstract][Full Text] [Related]
12. Dendritic Cell Leukemia: a Review.
Tsagarakis NJ; Paterakis G
Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
[TBL] [Abstract][Full Text] [Related]
13. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Jain A; Sweet K
J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
[TBL] [Abstract][Full Text] [Related]
14. Neoplasms derived from plasmacytoid dendritic cells.
Facchetti F; Cigognetti M; Fisogni S; Rossi G; Lonardi S; Vermi W
Mod Pathol; 2016 Feb; 29(2):98-111. PubMed ID: 26743477
[TBL] [Abstract][Full Text] [Related]
15. E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Lorenzi L; Lonardi S; Vairo D; Bernardelli A; Tomaselli M; Bugatti M; Licini S; Arisi M; Cerroni L; Tucci A; Vermi W; Giliani SC; Facchetti F
Am J Surg Pathol; 2021 Oct; 45(10):1428-1438. PubMed ID: 34081040
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
[TBL] [Abstract][Full Text] [Related]
17. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases].
Nong L; Wang W; Liang L; Li D; Li X; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):308-314. PubMed ID: 37042142
[TBL] [Abstract][Full Text] [Related]
18. A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body.
Cui XB; Jin J; Pang XL; Li S; Liu CX; Li TT; Peng H; Zhang SM; Li L; Liang WH; Chen YZ; Li F
Int J Clin Exp Pathol; 2014; 7(7):4391-9. PubMed ID: 25120824
[TBL] [Abstract][Full Text] [Related]
19. Blastic plasmacytoid dendritic cell neoplasm: A clinicopathological diagnostic dilemma report of three cases with review of literature.
Purkait S; Gupta S; Bakhshi S; Mallick S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S471-S474. PubMed ID: 36511007
[TBL] [Abstract][Full Text] [Related]
20. Use of classic and novel immunohistochemical markers in the diagnosis of cutaneous myeloid sarcoma.
Amador-Ortiz C; Hurley MY; Ghahramani GK; Frisch S; Klco JM; Lind AC; Nguyen TT; Hassan A; Kreisel FH; Frater JL
J Cutan Pathol; 2011 Dec; 38(12):945-53. PubMed ID: 22050091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
